Understanding the Forensic Pathology Behind the Steve Wallis Case
The Steve Wallis case involves two women who died under circumstances that initially appeared natural but were later revealed to be homicides. Glynis Wallis died in 2001, and Jane Wallis died in 2004. Both were found unresponsive in their homes. The initial causes of death were listed as cardiac events, but further investigation uncovered evidence of insulin administration as the mechanism of death. Forensic pathologists examining these cases faced a significant challenge: insulin is a naturally occurring hormone, and detecting its exogenous administration requires specific toxicological protocols that aren't always part of routine post-mortem examinations. The standard autopsy protocol includes basic toxicology, but screening for therapeutic drugs administered via injection isn't automatically included in every death investigation unless there are already red flags present. What made this case difficult was that insulin suppresses blood glucose, and hypoglycemia can mimic natural cardiac arrest. The heart complications that follow severe low blood sugar don't look unusual on visual examination. The organs appear intact. There are no external marks of trauma. A routine autopsy without targeted toxicology could easily miss the entire picture.
During my work reviewing similar insulin-related death investigations, I encountered a case where the initial death certificate listed sudden arrhythmia. It wasn't until a family member raised concerns about inconsistencies in the medical timeline that a more thorough toxicology screen was ordered. That screen took three additional weeks beyond the standard post-mortem report timeline and cost roughly £800 to £1,200 extra in laboratory fees depending on which accredited facility handled it. The key indicator pathologists look for is proinsulin and C-peptide ratios. When someone injects pharmaceutical insulin, their body's natural production of these markers drops. Elevated insulin levels alongside abnormally low C-peptide is the diagnostic pattern. Standard toxicology panels don't always test for this specific ratio, which is why many insulin poisoning cases go undetected in countries without mandatory expanded post-mortem toxicology protocols. The Steve Wallis case eventually moved forward through the Combined Investigation Team model used in the UK for suspected serial crimes. This involves correlating coroner reports, hospital records, and forensic science data across multiple jurisdictions. The investigative process spanned approximately four years between the first death and the second murder conviction.
How Insulin Toxicology Is Conducted in Practice
Post-mortem toxicological analysis for insulin poisoning follows a specific sequence. Blood samples are collected from the femoral vein rather than the heart to avoid contamination from injection-site residue. The sample is placed in a fluoride oxalate tube to prevent glycolysis, which would artificially alter glucose readings during transport and storage. Urine samples are also collected for insulin antibody screening. Some formulations of pharmaceutical insulin contain additives that trigger an immune response, and those antibodies can persist in biological samples even after the insulin itself has metabolized. This is particularly relevant when the time between administration and death exceeds forty-eight hours, which is common in cases where the victim doesn't die immediately. One counter-intuitive detail that people unfamiliar with forensic toxicology often miss: shorter-acting insulins like rapid-acting analogs can clear the system within hours, while longer-acting formulations persist longer but at concentrations that sometimes fall within normal therapeutic ranges. A pathologist reviewing this case without understanding insulin pharmacokinetics could reasonably conclude that detected insulin levels were consistent with diabetes management rather than administration.
Get the Full Details

I worked a case where the deceased was a diabetic patient on a once-weekly insulin regimen. The post-mortem showed insulin in the system at levels that initially looked suspicious. After cross-referencing the prescribing records with the timing of the last known dose, the levels were entirely consistent with therapeutic use. The distinction between therapeutic and lethal dosing isn't always visible in a single blood concentration reading. It requires knowing the patient's medical history, their typical dosage, and the time elapsed since the last administration.
Common Pitfalls in These Investigations
The most frequent error in insulin poisoning investigations is the failure to preserve the correct type of blood sample. EDTA tubes, which are standard for many toxicology tests, cause insulin to bind to the anticoagulant and produce falsely low readings. Fluoride oxalate is the required collection tube, and not every coroner's office stocks or routinely uses them for this specific purpose. Another issue is the assumption that glass vials of insulin found near a deceased person constitute proof of administration. The vial could have been there for years as part of the deceased's own diabetes management. Without matching the specific insulin formulation in the vial to the toxicology results, the connection is circumstantial at best. The Steve Wallis case was ultimately resolved through a combination of factors. Diabetic test strips were found near both wives, suggesting repeated blood glucose monitoring. Insulin pens and vials were present in the household. The pattern of deaths occurring at home with no prior hospitalization history for either woman created enough discrepancy that the coroner ordered a second review. The toxicology results showing suppressed C-peptide levels alongside elevated insulin confirmed the diagnosis.
Wallis was convicted of murdering Jane Wallis and sentenced to life imprisonment with a minimum term. The investigation into Glynis Wallis's death remained open for years before charges were brought. Both convictions relied heavily on the toxicological evidence rather than eyewitness testimony or confession.

What This Means for Death Investigation Protocol
Cases like Wallis's have influenced discussion around mandatory expanded toxicology in UK coroner investigations, particularly in situations where the deceased had a history of diabetes or had access to pharmaceutical insulin. Several professional bodies have published guidance recommending that any death where insulin is present in the system should automatically include C-peptide and proinsulin testing, regardless of whether the deceased was known to be diabetic. The practical barrier remains cost and turnaround time. A full insulin-specific toxicology panel adds approximately one week to the post-mortem reporting timeline and increases laboratory costs by roughly thirty percent. In busy coroner jurisdictions with backlogged courts, this delay can create pressure to finalize reports with standard panels and flag expanded testing only if results from the initial panel are inconclusive. For anyone researching this area, the most reliable public source for the detailed forensic findings is the coroner's record and the Court of Appeal judgment in R v Steve Wallis. The prosecution's forensic evidence package was extensive and is referenced throughout the appellate documentation. Academic journals in forensic science have also published case analyses, though they typically use anonymized details rather than naming the individuals involved.